Inventor · disambiguated record
Mark L. Peterson
Also filed as: PETERSON MARK · PETERSON MARK L · PETERSON MARK LOUIS
25 granted patents·8 pending applications·278 citations·filing 1990–2024
96Inventor score
Files withTRANZYME PHARMA INC10CYCLENIUM PHARMA INC5OCERA THERAPEUTICS INC4FRASER GRAEME L3MARSAULT ERIC3
Top patents by PatentIndex Score
33 records- 0195US7491695B2Methods of using macrocyclic modulators of the ghrelin receptorTRANZYME PHARMA INC·Filed 2005·Granted Feb 17, 2009·39 cites·18 claims
- 0295US7476653B2Macrocyclic modulators of the ghrelin receptorTRANZYME PHARMA INC·Filed 2005·Granted Jan 13, 2009·48 cites·14 claims
- 0394USRE42624EMethods of using macrocyclic modulators of the ghrelin receptorTRANZYME PHARMA INC·Filed 2009·Granted Aug 16, 2011·17 cites·18 claims
- 0494US7521420B2Macrocyclic antagonists of the motilin receptorTRANZYME PHARMA INC·Filed 2004·Granted Apr 21, 2009·46 cites·12 claims
- 0592US8088733B2Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disordersFRASER GRAEME L·Filed 2007·Granted Jan 3, 2012·22 cites·16 claims
- 0692USRE42013EMacrocyclic modulators of the ghrelin receptorTRANZYME PHARMA INC·Filed 2009·Granted Dec 28, 2010·18 cites·14 claims
- 0789US8349887B2Methods of treating cachexia with macrocyclic modulators of the ghrelin receptorTRANZYME PHARMA INC·Filed 2011·Granted Jan 8, 2013·11 cites·6 claims
- 0887US8450268B2Methods of using macrocyclic modulators of the ghrelin receptorFRASER GRAEME L·Filed 2008·Granted May 28, 2013·10 cites·8 claims
- 0985US7452862B2Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonistsTRANZYME PHARMA INC·Filed 2004·Granted Nov 18, 2008·23 cites·4 claims
- 1081US7550431B2Spatially-defined macrocycles incorporating peptide bond surrogatesTRANZYME PHARMA INC·Filed 2004·Granted Jun 23, 2009·16 cites·3 claims
- 1180US8022252B2Spatially-defined macrocyclic compounds useful for drug discoveryTRANZYME PHARMA INC·Filed 2008·Granted Sep 20, 2011·4 cites·3 claims
- 1275US5126452ASynthesis of purine substituted cyclopentene derivativesGLAXO INC·Filed 1990·Granted Jun 30, 1992·16 cites·10 claims
- 1374US8440851B2Spatially-defined macrocyclic compounds useful for drug discoveryMARSAULT ERIC·Filed 2011·Granted May 14, 2013·2 cites·5 claims
- 1468US2025057351A1Apparatus for cold-brewed coffee and other beverages using pefPETERSON MARK L·Filed 2024·Application pending·0 cites
- 1566US10407442B2Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the sameCYCLENIUM PHARMA INC·Filed 2016·Granted Sep 10, 2019·1 cites·20 claims
- 1666US9181298B2Intermediates for macrocyclic compoundsMARSAULT ERIC·Filed 2008·Granted Nov 10, 2015·0 cites·3 claims
- 1765US10981931B2Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the sameCYCLENIUM PHARMA INC·Filed 2019·Granted Apr 20, 2021·0 cites·4 claims
- 1863US9753019B2Measuring nitric oxide in fluidLIFEHEALTH LLC·Filed 2014·Granted Sep 5, 2017·1 cites·19 claims
- 1962US10258602B2Macrocyclic ghrelin receptor modulators and methods of using the sameOCERA THERAPEUTICS INC·Filed 2018·Granted Apr 16, 2019·0 cites·16 claims
- 2060US10040751B2Intermediates for macrocyclic compoundsOCERA THERAPEUTICS INC·Filed 2015·Granted Aug 7, 2018·0 cites·21 claims
- 2159US8497242B2Processes for intermediates for macrocyclic compoundsMARSAULT ERIC·Filed 2011·Granted Jul 30, 2013·0 cites·15 claims
- 2257US9949949B2Macrocyclic ghrelin receptor modulators and methods of using the sameOCERA THERAPEUTICS INC·Filed 2016·Granted Apr 24, 2018·0 cites·11 claims
- 2357US8557765B2Spatially-defined macrocycles incorporating peptide bond surrogatesDESLONGCHAMPS PIERRE·Filed 2009·Granted Oct 15, 2013·0 cites·2 claims
- 2455US2021284655A1Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the sameCYCLENIUM PHARMA INC·Filed 2021·Application pending·0 cites
- 2554US9371297B2Macrocyclic ghrelin receptor modulators and methods of using the sameHOVEYDA HAMID·Filed 2008·Granted Jun 21, 2016·0 cites·4 claims
- 2654US5241069ACarbonate intermediates for the synthesis of purine substituted cyclopentene derivativesGLAXO INC·Filed 1991·Granted Aug 31, 1993·4 cites·2 claims
- 2751US2009198050A1Macrocyclic Modulators of the Ghrelin ReceptorTRANZYME PHARMA INC·Filed 2008·Application pending·0 cites
- 2848US9651530B2Methods and apparatus for measuring nitric oxide in fluidLIFEHEALTH LLC·Filed 2013·Granted May 16, 2017·0 cites·18 claims
- 2946US2012071412A1Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disordersFRASER GRAEME L·Filed 2011·Application pending·0 cites
- 3044US2018110824A1Macrocyclic Modulators of the Ghrelin ReceptorOCERA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3137US2019153620A1Libraries of diverse macrocyclic compounds and methods of making and using the sameCYCLENIUM PHARMA INC·Filed 2017·Application pending·0 cites
- 3235US2020190083A1Libraries of pyridine-containing macrocyclic compounds and methods of making and using the sameCYCLENIUM PHARMA INC·Filed 2018·Application pending·0 cites
- 3326US2011105389A1Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the SameHOVEYDA HAMID R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark L. Peterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →